Globally there are an estimated 3 million people that are in need of arm prosthetics. Standard prosthetics are expensive, and they need to be replaced every 3 to 5 years, making it a burden on those who need it. Standard prosthetics also do not give users the range of motion and freedom need to be most useful to them. Only a small proportion of amputees can afford high tech protheses. Adam’s Hand (A Dialogic, Adaptive, Modular, Sensitive Hand) is an innovative myoelectric hand prosthesis based on a revolutionary mechanism – patented in Italy, patent-pending in EU, USA, China, India - that moves all fingers with just one motor (instead of the state-of-the-art 5-6 motors poli-articulated devices), making it extremely easy to control. Adam’s Hand provides a fuller range of motion and control for users, acting more like a living hand, also being lighter, more compact, less loud and presenting higher autonomy. The number of people who will require an amputation will double by 2050. Having a device that allows you to have a functioning limb will allow people to have more freedom in their everyday lives. Adam’s Hand’s innovation represents a growing trend in the mechatronic research field, allowing for the design of robust, lightweight and easy-to-control end-effectors and in high-resistance 3D printing that allows for the fast production of tailor-made and highly-customizable prosthetic devices. This gives us a SOM of €300 million. People with disabilities make an enormous contribution to European society, but often face barriers that prevent them from participating in society on an equal basis with others. At BionIT Labs, our mission is to improve the quality of life for people with disabilities by creating innovative and affordable technology that can “Turn their disabilities into New Possibilities”, allowing users to operate with ease in any environment.